Coppell Advisory Solutions LLC Lexicon Pharmaceuticals, Inc. Transaction History
Coppell Advisory Solutions LLC
- $502 Billion
- Q4 2023
A detailed history of Coppell Advisory Solutions LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 52 shares of LXRX stock, worth $83. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52
Previous 113
53.98%
Holding current value
$83
Previous $216,000
62.96%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LXRX
# of Institutions
122Shares Held
159MCall Options Held
2.11MPut Options Held
412K-
Artal Group S.A. Luxembourg, N4118MShares$188 Million15.21% of portfolio
-
Black Rock Inc. New York, NY7.69MShares$12.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.4MShares$10.2 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$5.67 Million0.19% of portfolio
-
Geode Capital Management, LLC Boston, MA2.39MShares$3.82 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $302M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...